In recent weeks, the FDA has faced significant cuts, including the layoffs of probationary employees. These employees, many ...
Key Takeaways Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review ...
A list with the file name "Prohibited words" has been circulating since at least last week in official work chats, according ...
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...
In September 2022, former President Biden convened the White House Conference on Hunger, Nutrition, and Health, during which ...
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
The FDA has determined that the nationwide shortage of semaglutide injection, used for both diabetes and weight loss, is resolved after more than two years of limited availability due to high demand.
PTC Therapeutics (PTCT) announced that the U.S. Food and Drug Administration, FDA, has accepted for filing the New Drug Application, NDA, for ...
The U.S. Food and Drug Administration (FDA) has accepted for filing PTC Therapeutics’ New Drug Application (NDA) for ...
Alvotech and Teva Pharmaceuticals said on Tuesday that the U.S. FDA has accepted for review a Biologics License Application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results